XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Restatement of Prior Financial Information (Tables)
9 Months Ended
Sep. 30, 2023
Restatement of Prior Financial Information  
Schedule of error corrections affecting the unaudited consolidated financial statements

(Unaudited)

    

March 31, 2023

    

March 31, 2023

CONSOLIDATED BALANCE SHEETS

As previously reported

Adjustments

As Restated

ASSETS

Non-current deposits

$

2,916

$

549

$

3,465

Total assets

$

22,060

$

549

$

22,609

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

  

Accrued and other current liabilities

$

4,829

$

119

$

4,948

Total current liabilities

 

7,338

 

119

7,457

Total liabilities

 

7,418

 

119

7,537

Accumulated deficit

 

(411,961)

 

430

(411,531)

Total stockholders’ equity

$

10,148

$

430

$

10,578

Total liabilities and stockholders’ equity

$

22,060

$

549

$

22,609

(Unaudited)

Three Months Ended March 31,

 

2023

    

2023

CONSOLIDATED STATEMENTS OF INCOME

As previously reported

Adjustments

As Restated

Net loss applicable to common shareholders

$

(5,854)

$

$

(5,854)

Basic and diluted earnings per common share:

Net Loss per share - basic and diluted (common shareholders)

$

(0.47)

$

$

(0.47)

Net Loss per share - basic and diluted (redeemable common shareholders)

$

$

(0.47)

$

(0.47)

(Unaudited)

    

March 31, 2023

    

March 31, 2023

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY

As previously reported

Adjustments

As Restated

Accumulated Deficit (Balances at December 31, 2022)

$

(406,157)

$

430

$

(405,727)

Accumulated Deficit (Balances at March 31, 2023)

$

(411,961)

$

430

$

(411,531)

Total Stockholders' Equity (Balances at March 31, 2023)

$

10,148

$

430

$

10,578

 

(Unaudited)

    

June 30, 2023

    

June 30, 2023

As previously

CONSOLIDATED BALANCE SHEETS

reported

Adjustments

As Restated

ASSETS

Non-current deposits

$

1,000

$

549

$

1,549

Total assets

$

16,442

$

549

$

16,991

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

  

 

Accrued and other current liabilities

$

4,577

$

119

$

4,696

Total current liabilities

 

6,746

 

119

 

6,865

Total liabilities

 

6,812

 

119

 

6,931

Temporary equity

$

4,494

$

(1,105)

$

3,389

Common Stock

9

1

10

Additional Paid-In Capital

423,633

 

1,104

 

424,737

Accumulated deficit

 

(417,409)

 

430

 

(416,979)

Total stockholders’ equity

 

5,136

 

1,535

 

6,671

Total liabilities and stockholders’ equity

$

16,442

$

549

$

16,991

(Unaudited)

Three Months Ended June 30,

Six Months Ended June 30,

 

2023

    

2023

 

2023

    

2023

CONSOLIDATED STATEMENTS OF INCOME

As previously reported

Adjustments

As Restated

As previously reported

Adjustments

As Restated

Net loss applicable to common shareholders

$

(5,498)

$

$

(5,498)

$

(11,353)

$

$

(11,353)

Basic and diluted earnings per common share:

Net Loss per share - basic and diluted (common shareholders)

$

(0.44)

$

$

(0.44)

$

(0.91)

$

$

(0.90)

Net Loss per share - basic and diluted (redeemable common shareholders)

$

$

(0.44)

$

(0.44)

$

$

(0.90)

$

(0.90)

 

(Unaudited)

    

June 30, 2023

    

June 30, 2023

CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY

As previously reported

Adjustments

As Restated

Accumulated Deficit (Balances at December 31, 2022)

$

(406,157)

$

430

$

(405,727)

Accumulated Deficit (Balances at March 31, 2023)

$

(411,961)

$

430

$

(411,531)

Total Stockholders' Equity (Balances at March 31, 2023)

$

10,148

$

430

$

10,578

Common Stock - Issue of common stock on At Market, net of expenses

$

$

1

$

1

Common Stock (Balances at June 30, 2023)

$

9

$

1

$

10

Additional Paid-In Capital - Issue of common stock on At Market, net of expenses

$

$

1,104

$

1,104

Additional Paid-In Capital (Balances at June 30, 2023)

$

423,633

$

1,104

$

424,737

Accumulated Deficit (Balances at June 30, 2023)

$

(417,409)

$

430

$

(416,979)

Total Stockholders' Equity (Balances at June 30, 2023)

$

5,136

$

1,535

$

6,671

Common Stock No. Shares (Reclassification of redeemable common stock)

798,200

798,200

Common Stock No. Shares (Balance at June 30, 2023)

9,422,089

798,200

10,220,289